as soon as  is submitted to ZB.
		
    
        
        FASEB J. 22, 437-444 (2008)
    
    
    
	    With HIV persisting lifelong in infected persons, therapeutic vaccination is a novel alternative concept to control virus replication. Even though CD8 and CD4 cell responses to such immunizations have been demonstrated, their effects on virus replication are still unclear. In view of this fact, we studied the impact of a therapeutic vaccination with HIV nef delivered by a recombinant modified vaccinia Ankara vector on viral diversity. We investigated HIV sequences derived from chronically infected persons before and after therapeutic vaccination. Before immunization the mean +/- se pairwise variability of patient-derived Nef protein sequences was 0.1527 +/- 0.0041. After vaccination the respective value was 0.1249 +/- 0.0042, resulting in a significant (P<0.0001) difference between the two time points. The genes vif and 5'gag tested in parallel and nef sequences in control persons yielded a constant amino acid sequence variation. The data presented suggest that Nef immunization induced a selective pressure, limiting HIV sequence variability. To our knowledge this is the first report directly linking therapeutic HIV vaccination to decreasing diversity in patient-derived virus isolates.
	
	
      Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		
		Times Cited
Altmetric
		
	    6.791
		1.630
		8
		
		
	    Annotations
	    
		
		     
		    
		
	    
	
		
	
	    Special Publikation
	    
		
		     
		
	    
	
	
	
	    Hide on homepage
	    
		
		     
		
	    
	
	
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
     
    
    
        Keywords
        Nef; genetic diversity; selection
    
 
     
    
    
        Language
        english
    
 
    
        Publication Year
        2008
    
 
     
    
        HGF-reported in Year
        0
    
 
    
    
        ISSN (print) / ISBN
        0892-6638
    
 
    
        e-ISSN
        1530-6860
    
 
    
     
     
	     
	 
	 
    
        Journal
        FASEB Journal
    
 
	
    
        Quellenangaben
        
	    Volume: 22,  
	    Issue: 2,  
	    Pages: 437-444 
	    
	    
	
    
 
    
         
        
            Publisher
            Wiley
        
 
        
            Publishing Place
            Bethesda, Md.
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Reviewing status
        Peer reviewed
    
 
     
    
        POF-Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Research field(s)
        Immune Response and Infection
    
 
    
        PSP Element(s)
        G-502700-002
G-520400-001
 
     
     	
    G-520400-001
        PubMed ID
        17932027
    
    
    
        WOS ID
        000252822600014
    
    
        Erfassungsdatum
        2008-03-10